With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be acquired next.

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Pfizer (NYSE: PFE) has been around for 175 years, but the company's revenue soared to its highest ever only in more recent ...

There's nothing swampier than handing over billions of taxpayer dollars to a pharmaceutical company that had already gotten rich off the coronavirus pandemic.

Wegovy maker Novo Nordisk is accusing Mr Huang and his firm of fraudulent claims over a hypertension drug. Read more at ...

Pharmaceutical giant Moderna (MRNA) released mixed fourth quarter results on Friday, posting revenue of $966 million (higher than the consensus estimate of $954 million) alongside a wider-than ...

Pharma company Ami Organics Ltd. saw its shares gain momentum today, with the stock rising by up to 3.7% in early trade.

Private equity-backed US pharmaceutical giant Cosette has made a $672 million ... but a fraction of the $42 it was trading at in 2016. Mayne Pharma sells products in Australia and the US for ...

On a call with Wall Street analysts after the Fortune 500 company reported its 2024 results, CEO Erik Fyrwald made it clear that acquisitions were back on the table—but with a more disciplined ...

Pharmaceutical giant Moderna (MRNA) released mixed fourth quarter results on Friday, posting revenue of $966 million (higher than the consensus estimate of $954 million) alongside a ...